Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters

JAMA. 2022 Jul 26;328(4):393-395. doi: 10.1001/jama.2022.9734.

Abstract

This study examines the frequency of product recalls and the presence of FDA-prohibited drugs in supplements after FDA warning letters.

MeSH terms

  • Dietary Supplements* / adverse effects
  • Dietary Supplements* / analysis
  • Dietary Supplements* / supply & distribution
  • Drug Recalls*
  • Product Recalls and Withdrawals
  • United States
  • United States Food and Drug Administration*